SHIXIA HUANG to Neuroblastoma
This is a "connection" page, showing publications SHIXIA HUANG has written about Neuroblastoma.
Connection Strength
0.181
-
Regorafenib is effective against neuroblastoma in vitro and in vivo and inhibits the RAS/MAPK, PI3K/Akt/mTOR and Fos/Jun pathways. Br J Cancer. 2020 08; 123(4):568-579.
Score: 0.117
-
An integrated proteomic approach to identifying circulating biomarkers in high-risk neuroblastoma and their potential in relapse monitoring. Proteomics Clin Appl. 2011 Oct; 5(9-10):532-41.
Score: 0.064